KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 56 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $53,743 | +67.6% | 3,094 | +35.8% | 0.00% | +100.0% |
Q2 2023 | $32,074 | +30.9% | 2,278 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $24,511 | -23.1% | 2,278 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $31,892 | +10.0% | 2,278 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $29,000 | +31.8% | 2,278 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $22,000 | -4.3% | 2,278 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $23,000 | -14.8% | 2,278 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $27,000 | +3.8% | 2,278 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $26,000 | -18.8% | 2,278 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $32,000 | -23.8% | 2,278 | 0.0% | 0.00% | -50.0% |
Q1 2021 | $42,000 | +5.0% | 2,278 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $40,000 | +14.3% | 2,278 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $35,000 | -18.6% | 2,278 | +35.6% | 0.00% | 0.0% |
Q2 2020 | $43,000 | +186.7% | 1,680 | +72.3% | 0.00% | +100.0% |
Q1 2020 | $15,000 | +36.4% | 975 | 0.0% | 0.00% | – |
Q4 2019 | $11,000 | +37.5% | 975 | 0.0% | 0.00% | – |
Q3 2019 | $8,000 | -38.5% | 975 | 0.0% | 0.00% | -100.0% |
Q2 2019 | $13,000 | +30.0% | 975 | +82.2% | 0.00% | – |
Q1 2019 | $10,000 | -33.3% | 535 | 0.0% | 0.00% | -100.0% |
Q4 2018 | $15,000 | +7.1% | 535 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $14,000 | – | 535 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 1,025,000 | $12,064,000 | 2.56% |
GREAT POINT PARTNERS LLC | 536,738 | $6,317,000 | 1.40% |
Endurant Capital Management LP | 244,125 | $2,873,000 | 0.69% |
HHLR ADVISORS, LTD. | 2,920,023 | $34,369,000 | 0.53% |
Integral Health Asset Management, LLC | 140,000 | $1,648,000 | 0.46% |
Spearhead Capital Advisors, LLC | 235,024 | $2,766,000 | 0.33% |
Jackson Creek Investment Advisors LLC | 77,069 | $907,000 | 0.32% |
RICE HALL JAMES & ASSOCIATES, LLC | 712,807 | $8,390,000 | 0.30% |
Parkman Healthcare Partners LLC | 113,644 | $1,338,000 | 0.30% |
Birchview Capital, LP | 30,000 | $353,000 | 0.23% |